Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
Public ClinicalTrials.gov record NCT01233960. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label Study to Evaluate the Safety of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects Who Have Received Previous Remestemcel-L Induction Treatment for Treatment-refractory Moderate-to-severe Crohn's Disease
Study identification
- NCT ID
- NCT01233960
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Mesoblast, Inc.
- Industry
- Enrollment
- 73 participants
Conditions and interventions
Conditions
Interventions
- Prochymal® Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 28, 2010
- Primary completion
- Sep 14, 2014
- Completion
- Sep 14, 2014
- Last update posted
- Mar 10, 2026
2010 – 2014
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94115 | — |
| Clinical Research of West Florida | Clearwater | Florida | 33765 | — |
| Shafran Gastroenterology Center | Winter Park | Florida | 32789 | — |
| University of Chicago | Chicago | Illinois | 60611 | — |
| Cotton-O'Neil Clinical Research Center | Topeka | Kansas | 66606 | — |
| University of Maryland, Baltimore | Baltimore | Maryland | 21201 | — |
| Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Saint Louis Center for Clinical Research | St Louis | Missouri | 63128 | — |
| St. Louis Center for Clinical Studies | St Louis | Missouri | 63128 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Weill Cornell Medical College | New York | New York | 10028 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Gastroenterology Center of the Midsouth, PC | Germantown | Tennessee | 38138 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| McGuire Research Institute | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01233960, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01233960 live on ClinicalTrials.gov.